FDA Inspection
Texoma Regional Blood CenterTexoma Regional Blood Center – FDA Inspection, May 3, 2019
Record Details
This FDA Inspection record concerns Texoma Regional Blood Center, with an inspection on May 3, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 301595a4-8412-4c57-a970-b7ed6ff6e142
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1088682
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 630.30(b)(2)Unsuitable donation - defer testing
- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Texoma Regional Blood Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 23, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 30, 2017 | Not classified | Dallas District Office | |
| February 20, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 13, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 9, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Texoma Regional Blood Center
- FDA Inspection 1247483 - 2024-08-23
- FDA Inspection 1003237 - 2017-01-30
- FDA Inspection 915249 - 2015-02-20
- FDA Inspection 810912 - 2012-12-13
- FDA Inspection 700321 - 2010-12-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.